Free agent Tyler Mahle delivered a strong two‑month run with Atlanta to close the regular season, then excelled in the playoffs and voiced interest in returning.
Atlanta’s trade‑deadline moves barely made a ripple, adding Lane Thomas and relievers Bailey Falter, Brent Suter and Tyler Uberstine. Mahle, the headline grab, posted a 5.13 ERA in 18 starts for the Giants before swingman Anthony Molina secured his Braves deal.
Mahle burst onto the scene, blanking the Yankees for six innings in his debut. He surrendered just seven earned runs across his first eight starts, shook off a rough final regular‑season outing and then turned in two stellar playoff efforts – a one‑run, seven‑inning gem against the Phillies and a stretch into the seventh inning versus the Dodgers, though neither sparked a win.
The Giants signed Mahle to a modest one‑year, $10 million contract, a prove‑it deal with innings incentives after injuries limited him to 24 starts over three seasons. He didn’t shine in San Francisco, but his Braves stint could revive his market value.
Atlanta entered 2026 with a seemingly deep rotation, only to see injuries bite: Spencer Strider and Hurston Waldrep combined for 11 games, while Spencer Schwellenbach and Joey Wentz never took the mound. Reynaldo Lopez, Bryce Elder and Martin Perez missed the postseason, leaving Sale, Mahle and a bullpen anchored by Ray Kerr and Grant Holmes by October.
Waldrep and Schwellenbach face uncertain 2027 returns after elbow surgery, but the rest should be healthy. The Braves lack a clear veteran need, yet that was true at season start; for my money, Mahle could be a low‑cost boost. Will Atlanta sign him before free agency opens?